As of 2025-09-15, the Relative Valuation of Moderna Inc (MRNA) is (102.22) USD. This relative valuation is based on P/E multiples. With the latest stock price at 23.51 USD, the upside of Moderna Inc based on Relative Valuation is -534.8%.
The range of the Relative Valuation is (101.17) - (105.50) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.5x - 14.1x | 13.3x |
| Forward P/E multiples | 13.6x - 15.4x | 14.1x |
| Fair Price | (101.17) - (105.50) | (102.22) |
| Upside | -530.3% - -548.8% | -534.8% |
| Date | P/E |
| 2025-09-12 | -3.15 |
| 2025-09-11 | -3.40 |
| 2025-09-10 | -3.26 |
| 2025-09-09 | -3.28 |
| 2025-09-08 | -3.33 |
| 2025-09-05 | -3.37 |
| 2025-09-04 | -3.25 |
| 2025-09-03 | -3.22 |
| 2025-09-02 | -3.24 |
| 2025-08-29 | -3.23 |
| 2025-08-28 | -3.28 |
| 2025-08-27 | -3.36 |
| 2025-08-26 | -3.31 |
| 2025-08-25 | -3.40 |
| 2025-08-22 | -3.63 |
| 2025-08-21 | -3.51 |
| 2025-08-20 | -3.60 |
| 2025-08-19 | -3.74 |
| 2025-08-18 | -3.76 |
| 2025-08-15 | -3.76 |
| 2025-08-14 | -3.58 |
| 2025-08-13 | -3.60 |
| 2025-08-12 | -3.44 |
| 2025-08-11 | -3.41 |
| 2025-08-08 | -3.50 |
| 2025-08-07 | -3.57 |
| 2025-08-06 | -3.58 |
| 2025-08-05 | -3.68 |
| 2025-08-04 | -3.70 |
| 2025-08-01 | -3.70 |
| 2025-07-31 | -3.96 |
| 2025-07-30 | -4.31 |
| 2025-07-29 | -4.38 |
| 2025-07-28 | -4.54 |
| 2025-07-25 | -4.58 |
| 2025-07-24 | -4.56 |
| 2025-07-23 | -4.65 |
| 2025-07-22 | -4.39 |
| 2025-07-21 | -4.15 |
| 2025-07-18 | -4.19 |
| 2025-07-17 | -4.32 |
| 2025-07-16 | -4.30 |
| 2025-07-15 | -4.23 |
| 2025-07-14 | -4.41 |
| 2025-07-11 | -4.51 |
| 2025-07-10 | -4.59 |
| 2025-07-09 | -4.39 |
| 2025-07-08 | -4.36 |
| 2025-07-07 | -4.01 |
| 2025-07-03 | -4.09 |